FY26 ALS Research Program Therapeutic Idea Award for new high-risk ideas
The FY26 Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award funds new, innovative, high-risk, high-reward projects focused on ALS drug or therapy discovery. Proposals should be hypothesis-driven and aim to produce preliminary data to support future therapeutic directions. Strong applications emphasize the soundness and interpretability of the approach even if preliminary dat…
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Idea Award (TIA) supports new, innovative, high-risk, high-gain ideas aimed at amyotrophic lateral sclerosis (ALS) drug or therapy discovery. The studies supported by this awa…
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers